These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22292024)

  • 1. The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells.
    Rappl G; Riet T; Awerkiew S; Schmidt A; Hombach AA; Pfister H; Abken H
    PLoS One; 2012; 7(1):e30713. PubMed ID: 22292024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor.
    Asai H; Fujiwara H; An J; Ochi T; Miyazaki Y; Nagai K; Okamoto S; Mineno J; Kuzushima K; Shiku H; Inoue H; Yasukawa M
    PLoS One; 2013; 8(2):e56820. PubMed ID: 23441216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling.
    Ardouin L; Boyer C; Gillet A; Trucy J; Bernard AM; Nunes J; Delon J; Trautmann A; He HT; Malissen B; Malissen M
    Immunity; 1999 Apr; 10(4):409-20. PubMed ID: 10229184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
    Barden M; Holzinger A; Velas L; Mezősi-Csaplár M; Szöőr Á; Vereb G; Schütz GJ; Hombach AA; Abken H
    Front Immunol; 2023; 14():1110482. PubMed ID: 36817444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD3 delta establishes a functional link between the T cell receptor and CD8.
    Doucey MA; Goffin L; Naeher D; Michielin O; Baumgärtner P; Guillaume P; Palmer E; Luescher IF
    J Biol Chem; 2003 Jan; 278(5):3257-64. PubMed ID: 12215456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.
    Isomäki P; Panesar M; Annenkov A; Clark JM; Foxwell BM; Chernajovsky Y; Cope AP
    J Immunol; 2001 May; 166(9):5495-507. PubMed ID: 11313388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress is involved in the heat stress-induced downregulation of TCR zeta chain expression and TCR/CD3-mediated [Ca(2+)](i) response in human T-lymphocytes.
    Nambiar MP; Fisher CU; Enyedy EJ; Warke VG; Kumar A; Tsokos GC
    Cell Immunol; 2002 Feb; 215(2):151-61. PubMed ID: 12202152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of phosphatidylinositol 3-kinase with a specific sequence of the T cell receptor zeta chain is dependent on T cell activation.
    Exley M; Varticovski L; Peter M; Sancho J; Terhorst C
    J Biol Chem; 1994 May; 269(21):15140-6. PubMed ID: 8195151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
    Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
    Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of constitutive TCR internalization by the zeta-chain.
    D'Oro U; Munitic I; Chacko G; Karpova T; McNally J; Ashwell JD
    J Immunol; 2002 Dec; 169(11):6269-78. PubMed ID: 12444133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
    Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between the human TCR/CD3 epsilon and the B-cell antigen receptor associated Ig-beta (B29).
    Müller B; Cooper L; Terhorst C
    Immunol Lett; 1995 Jan; 44(2-3):97-103. PubMed ID: 7541024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, sequencing and expression of the bovine CD3 epsilon and TCR-zeta chains, two invariant components of the T-cell receptor complex.
    Hagens G; Galley Y; Glaser I; Davis WC; Baldwin CL; Clevers H; Dobbelaere DA
    Gene; 1996 Mar; 169(2):165-71. PubMed ID: 8647441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.
    Moingeon P; Lucich JL; McConkey DJ; Letourneur F; Malissen B; Kochan J; Chang HC; Rodewald HR; Reinherz EL
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1492-6. PubMed ID: 1346934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
    Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
    BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor microclusters critical for T-cell activation are formed independently of lipid raft clustering.
    Hashimoto-Tane A; Yokosuka T; Ishihara C; Sakuma M; Kobayashi W; Saito T
    Mol Cell Biol; 2010 Jul; 30(14):3421-9. PubMed ID: 20498282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs.
    Miyao K; Terakura S; Okuno S; Julamanee J; Watanabe K; Hamana H; Kishi H; Sakemura R; Koyama D; Goto T; Nishida T; Murata M; Kiyoi H
    Cancer Immunol Res; 2018 Jun; 6(6):733-744. PubMed ID: 29653982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
    Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
    J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.
    Torikai H; Reik A; Liu PQ; Zhou Y; Zhang L; Maiti S; Huls H; Miller JC; Kebriaei P; Rabinovich B; Lee DA; Champlin RE; Bonini C; Naldini L; Rebar EJ; Gregory PD; Holmes MC; Cooper LJ
    Blood; 2012 Jun; 119(24):5697-705. PubMed ID: 22535661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.